Design of Nucleic Acid Molecules for Predefined Purposes Peter - - PowerPoint PPT Presentation

design of nucleic acid molecules for predefined purposes
SMART_READER_LITE
LIVE PREVIEW

Design of Nucleic Acid Molecules for Predefined Purposes Peter - - PowerPoint PPT Presentation

Design of Nucleic Acid Molecules for Predefined Purposes Peter Schuster Institut fr Theoretische Chemie, Universitt Wien, Austria and The Santa Fe Institute, Santa Fe, New Mexico, USA Viennano 2007 Wiener Neustadt, 14.03.2007 Web-Page for


slide-1
SLIDE 1
slide-2
SLIDE 2

Design of Nucleic Acid Molecules for Predefined Purposes Peter Schuster

Institut für Theoretische Chemie, Universität Wien, Austria and The Santa Fe Institute, Santa Fe, New Mexico, USA

Viennano 2007 Wiener Neustadt, 14.03.2007

slide-3
SLIDE 3

Web-Page for further information: http://www.tbi.univie.ac.at/~pks

slide-4
SLIDE 4

1. Nucleic acid structures 2. DNA nanotechnology 3. RNA – A magic molecule 4. Evolutionary optimization of structure 5. RNA design

slide-5
SLIDE 5
  • 1. Nucleic acid structures

2. DNA nanotechnology 3. RNA – A magic molecule 4. Evolutionary optimization of structure 5. RNA design

slide-6
SLIDE 6
slide-7
SLIDE 7

Canonical Watson-Crick base pairs: cytosine – guanine uracil – adenine (RNA) thymine – adenine (DNA)

W.Saenger, Principles of Nucleic Acid Structure, Springer, Berlin 1984

slide-8
SLIDE 8

The ‚replication fork‘ in DNA replication The mechanism of DNA replication is ‚semi-conservative‘

slide-9
SLIDE 9

O CH2 OH O O P O O O

N1

O CH2 OH O P O O O

N2

O CH2 OH O P O O O

N3

O CH2 OH O P O O O

N4

N A U G C

k =

, , ,

3' - end 5' - end Na Na Na Na

5'-end GCGGAUUUA

AGUUGGGA GCUC GAG

3’-end

AUUCGC G CUGAAGA AGGUC UUCGAUC A ACCA C CCAGA UCUGG CUGUG CACAG

slide-10
SLIDE 10

1. Nucleic acid structures

  • 2. DNA nanotechnology

3. RNA – A magic molecule 4. Evolutionary optimization of structure 5. RNA design

slide-11
SLIDE 11

Principle of DNA design shown for DNA-rod formation

slide-12
SLIDE 12

Formation of a stable Holliday junction N.D. Seeman, P.S. Lukeman. Nucleic acid nanostructure. Bottom-up control of geometry

  • n the nanoscale. Rep.Prog.Phys. 68:237-270, 2005.
slide-13
SLIDE 13

3D structure of a Holliday junction N.D. Seeman, P.S. Lukeman. Nucleic acid nanostructure. Bottom-up control of geometry

  • n the nanoscale. Rep.Prog.Phys. 68:237-270, 2005.
slide-14
SLIDE 14

Usage of Holliday junctions to construct DNA lattices

slide-15
SLIDE 15

Cube designed from DNA molecules N.D. Seeman, P.S. Lukeman. Nucleic acid nanostructure. Bottom-up control of geometry

  • n the nanoscale. Rep.Prog.Phys. 68:237-270, 2005.
slide-16
SLIDE 16

Truncated octahedron designed from DNA molecules N.D. Seeman, P.S. Lukeman. Nucleic acid nanostructure. Bottom-up control of geometry

  • n the nanoscale. Rep.Prog.Phys. 68:237-270, 2005.
slide-17
SLIDE 17

N.D. Seeman, P.S. Lukeman. Nucleic acid nanostructure. Bottom-up control of geometry

  • n the nanoscale. Rep.Prog.Phys. 68:237-270, 2005.
slide-18
SLIDE 18

1. Nucleic acid structures 2. DNA nanotechnology

  • 3. RNA – A magic molecule

4. Evolutionary optimization of structure 5. RNA design

slide-19
SLIDE 19

RNA

RNA as scaffold for supramolecular complexes

ribosome ? ? ? ? ?

Functions of RNA molecules

The world as a precursor of the current + biology RNA DNA protein

RNA as catalyst Ribozyme

RNA as carrier of genetic information

RNA viruses and retroviruses RNA evolution in vitro

slide-20
SLIDE 20

1. Nucleic acid structures 2. DNA nanotechnology 3. RNA – A magic molecule

  • 4. Evolutionary optimization of structure

5. RNA design

slide-21
SLIDE 21

Evolution of RNA molecules based on Qβ phage

D.R.Mills, R.L.Peterson, S.Spiegelman, An extracellular Darwinian experiment with a self-duplicating nucleic acid molecule. Proc.Natl.Acad.Sci.USA 58 (1967), 217-224 S.Spiegelman, An approach to the experimental analysis of precellular evolution. Quart.Rev.Biophys. 4 (1971), 213-253 C.K.Biebricher, Darwinian selection of self-replicating RNA molecules. Evolutionary Biology 16 (1983), 1-52 G.Bauer, H.Otten, J.S.McCaskill, Travelling waves of in vitro evolving RNA. Proc.Natl.Acad.Sci.USA 86 (1989), 7937-7941 C.K.Biebricher, W.C.Gardiner, Molecular evolution of RNA in vitro. Biophysical Chemistry 66 (1997), 179-192 G.Strunk, T.Ederhof, Machines for automated evolution experiments in vitro based on the serial transfer concept. Biophysical Chemistry 66 (1997), 193-202 F.Öhlenschlager, M.Eigen, 30 years later – A new approach to Sol Spiegelman‘s and Leslie Orgel‘s in vitro evolutionary studies. Orig.Life Evol.Biosph. 27 (1997), 437-457

slide-22
SLIDE 22

The mechanism of single stranded RNA replication

slide-23
SLIDE 23

RNA sample Stock solution: Q RNA-replicase, ATP, CTP, GTP and UTP, buffer

  • Time

1 2 3 4 5 6 69 70 Serial transfer technique for RNA evolution in the test tube

slide-24
SLIDE 24

Decrease in mean fitness due to quasispecies formation

The increase in RNA production rate during a serial transfer experiment

slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27
slide-28
SLIDE 28

Chemical kinetics of molecular evolution

  • M. Eigen, P. Schuster, `The Hypercycle´, Springer-Verlag, Berlin 1979
slide-29
SLIDE 29

Ij In I2 Ii I1 I j I j I j I j I j I j

+ + + + +

(A) + fj Qj1 fj Qj2 fj Qji fj Qjj fj Qjn Q (1- )

ij

  • d(i,j)

d(i,j)

=

l

p p

p .......... Error rate per digit d(i,j) .... Hamming distance between Ii and Ij ........... Chain length of the polynucleotide l

dx / dt = x - x x

i j j i j j

Σ

; Σ = 1 ; f f x

j j j i

Φ Φ = Σ Qji Qij

Σi

= 1 [A] = a = constant [Ii] = xi 0 ;

  • i =1,2,...,n ;

Chemical kinetics of replication and mutation as parallel reactions

slide-30
SLIDE 30

Formation of a quasispecies in sequence space

slide-31
SLIDE 31

Formation of a quasispecies in sequence space

slide-32
SLIDE 32

Formation of a quasispecies in sequence space

slide-33
SLIDE 33

Formation of a quasispecies in sequence space

slide-34
SLIDE 34

Uniform distribution in sequence space

slide-35
SLIDE 35

Quasispecies

The error threshold in replication

slide-36
SLIDE 36

Evolution in silico

  • W. Fontana, P. Schuster,

Science 280 (1998), 1451-1455

slide-37
SLIDE 37

Replication rate constant: fk = / [ + dS

(k)]

dS

(k) = dH(Sk,S)

Selection constraint: Population size, N = # RNA molecules, is controlled by the flow Mutation rate: p = 0.001 / site replication N N t N ± ≈ ) ( The flowreactor as a device for studies of evolution in vitro and in silico

slide-38
SLIDE 38

Randomly chosen initial structure Phenylalanyl-tRNA as target structure

slide-39
SLIDE 39

In silico optimization in the flow reactor: Evolutionary Trajectory

slide-40
SLIDE 40

28 neutral point mutations during a long quasi-stationary epoch Transition inducing point mutations change the molecular structure Neutral point mutations leave the molecular structure unchanged

Neutral genotype evolution during phenotypic stasis

slide-41
SLIDE 41

1. Nucleic acid structures 2. DNA nanotechnology 3. RNA – A magic molecule 4. Evolutionary optimization of structure

  • 5. RNA design
slide-42
SLIDE 42

Evolutionary design of RNA molecules

D.B.Bartel, J.W.Szostak, In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990), 818-822 C.Tuerk, L.Gold, SELEX - Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990), 505-510 D.P.Bartel, J.W.Szostak, Isolation of new ribozymes from a large pool of random sequences. Science 261 (1993), 1411-1418 R.D.Jenison, S.C.Gill, A.Pardi, B.Poliski, High-resolution molecular discrimination by RNA. Science 263 (1994), 1425-1429

  • Y. Wang, R.R.Rando, Specific binding of aminoglycoside antibiotics to RNA. Chemistry &

Biology 2 (1995), 281-290 Jiang, A. K. Suri, R. Fiala, D. J. Patel, Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex. Chemistry & Biology 4 (1997), 35-50

slide-43
SLIDE 43

Selection of molecules with predefined properties in laboratory experiments

slide-44
SLIDE 44

The SELEX technique for the evolutionary design of strong binders called aptamers

slide-45
SLIDE 45

tobramycin

A A A A A C C C C C C C C G G G G G G G G U U U U U U

5’- 3’-

A A A A A U U U U U U C C C C C C C C G G G G G G G G

5’-

  • 3’

RNA aptamer

Secondary structure of the tobramycin binding RNA aptamer with KD = 9 nM

  • L. Jiang, A. K. Suri, R. Fiala, D. J. Patel, Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA

aptamer complex. Chemistry & Biology 4:35-50 (1997)

slide-46
SLIDE 46

The three-dimensional structure of the tobramycin aptamer complex

  • L. Jiang, A. K. Suri, R. Fiala, D. J. Patel,

Chemistry & Biology 4:35-50 (1997)

slide-47
SLIDE 47

additional methyl group

Dissociation constants and specificity

  • f theophylline, caffeine, and related

derivatives of uric acid for binding to a discriminating aptamer TCT8-4

slide-48
SLIDE 48

Schematic drawing of the aptamer binding site for the theophylline molecule

slide-49
SLIDE 49

Hammerhead ribozyme – The smallest RNA based catalyst

H.W.Pley, K.M.Flaherty, D.B.McKay, Three dimensional structure of a hammerhead

  • ribozyme. Nature 372 (1994), 68-74

W.G.Scott, J.T.Finch, A.Klug, The crystal structures of an all-RNA hammerhead ribozyme: A proposed mechanism for RNA catalytic cleavage. Cell 81 (1995), 991-1002 J.E.Wedekind, D.B.McKay, Crystallographic structures of the hammerhead ribozyme: Relationship to ribozyme folding and catalysis. Annu.Rev.Biophys.Biomol.Struct. 27 (1998), 475-502 G.E.Soukup, R.R.Breaker, Design of allosteric hammerhead ribozymes activated by ligand- induced structure stabilization. Structure 7 (1999), 783-791

slide-50
SLIDE 50

theophylline

Allosteric effectors:

FMN = flavine mononucleotide H10 – H12 theophylline H14 Self-splicing allosteric ribozyme H13

Hammerhead ribozymes with allosteric effectors

slide-51
SLIDE 51

A ribozyme switch

E.A.Schultes, D.B.Bartel, Science 289 (2000), 448-452

slide-52
SLIDE 52

Two ribozymes of chain lengths n = 88 nucleotides: An artificial ligase (A) and a natural cleavage ribozyme of hepatitis--virus (B)

slide-53
SLIDE 53

The sequence at the intersection: An RNA molecule, which is 88 nucleotides long and which can form both structures.

slide-54
SLIDE 54

Two neutral walks through sequence space with conservation of structure and catalytic activity

slide-55
SLIDE 55

JN1LH

1D 1D 1D 2D 2D 2D R R R

G GGGUGGAAC GUUC GAAC GUUCCUCCC CACGAG CACGAG CACGAG

  • 28.6 kcal·mol
  • 1

G/

  • 31.8 kcal·mol
  • 1

G G G G G G C C C C C C A A U U U U G G C C U U A A G G G C C C A A A A G C G C A A G C /G

  • 28.2 kcal·mol
  • 1

G G G G G G GG CCC C C C C C U G G G G C C C C A A A A A A A A U U U U U G G C C A A

  • 28.6 kcal·mol
  • 1

3 3 3 13 13 13 23 23 23 33 33 33 44 44 44

5' 5' 3’ 3’

J.H.A. Nagel, C. Flamm, I.L. Hofacker, K. Franke, M.H. de Smit, P. Schuster, and C.W.A. Pleij. Structural parameters affecting the kinetic competition of RNA hairpin formation. Nucleic Acids Res. 34:3568-3576 (2006)

An experimental RNA switch

slide-56
SLIDE 56

4 5 8 9 11

1 9 2 2 4 2 5 2 7 3 3 3 4

36

38 39 41 46 47

3

49

1

2 6 7 10

1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 1 22 2 3 2 6 2 8 2 9 3 3 1 32 3 5 3 7

40

4 2 4 3 44 45 48 50

  • 26.0
  • 28.0
  • 30.0
  • 32.0
  • 34.0
  • 36.0
  • 38.0
  • 40.0
  • 42.0
  • 44.0
  • 46.0
  • 48.0
  • 50.0

2.77 5.32 2 . 9 3.4 2.36 2 . 4 4 2.44 2.44 1.46 1.44 1.66

1.9

2.14

2.51 2.14 2.51

2 . 1 4 1 . 4 7

1.49

3.04 2.97 3.04 4.88 6.13 6 . 8 2.89

Free energy [kcal / mole]

J1LH barrier tree

slide-57
SLIDE 57

Acknowledgement of support

Fonds zur Förderung der wissenschaftlichen Forschung (FWF) Projects No. 09942, 10578, 11065, 13093 13887, and 14898 Wiener Wissenschafts-, Forschungs- und Technologiefonds (WWTF) Project No. Mat05 Jubiläumsfonds der Österreichischen Nationalbank Project No. Nat-7813 European Commission: Contracts No. 98-0189, 12835 (NEST) Austrian Genome Research Program – GEN-AU: Bioinformatics Network (BIN) Österreichische Akademie der Wissenschaften Siemens AG, Austria Universität Wien and the Santa Fe Institute

Universität Wien

slide-58
SLIDE 58

Coworkers

Peter Stadler, Bärbel M. Stadler, Universität Leipzig, GE Paul E. Phillipson, University of Colorado at Boulder, CO Heinz Engl, Philipp Kügler, James Lu, Stefan Müller, RICAM Linz, AT Jord Nagel, Kees Pleij, Universiteit Leiden, NL Walter Fontana, Harvard Medical School, MA Christian Reidys, Christian Forst, Los Alamos National Laboratory, NM Ulrike Göbel, Walter Grüner, Stefan Kopp, Jaqueline Weber, Institut für Molekulare Biotechnologie, Jena, GE Ivo L.Hofacker, Christoph Flamm, Andreas Svrček-Seiler, Universität Wien, AT Kurt Grünberger, Michael Kospach , Andreas Wernitznig, Stefanie Widder, Stefan Wuchty, Universität Wien, AT Jan Cupal, Stefan Bernhart, Lukas Endler, Ulrike Langhammer, Rainer Machne, Ulrike Mückstein, Hakim Tafer, Thomas Taylor, Universität Wien, AT

Universität Wien

slide-59
SLIDE 59

Web-Page for further information: http://www.tbi.univie.ac.at/~pks

slide-60
SLIDE 60